Advertisement
News
Advertisement

GI Dynamics gets FDA OK for clinical trial

Thu, 08/23/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

GI Dynamics Inc. (ASX: GID) announced approval from the U.S. Food and Drug Administration (FDA) to skip the pilot trial usually required for medical devices, allowing the company to move directly into a pivotal clinical trial of its lead product, a device for the treatment of obese patients who have uncontrolled type 2 diabetes.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading